I've also come across reports that the reverse situation occurs. Some individuals find they need to begin titration again from a reduced dose upon resuming.
I've come across multiple discussions mentioning reduced or absent results from glp1s once someone stops using them and later resumes. Does this occur frequently? Are there standard approaches to prevent or lessen that possibility? I'm currently beginning to shed 10 pounds of fat during my recomp phase but intend to try the medication again later, so I'm interested in personal accounts or suggestions.